Fludarabin Infusion
Fludarabine phosphate
25mg/ml
Ebewe Pharma Ges. m.b.H Mfg. KG
| Pack size | 2ml Vial |
|---|---|
| Dispensing mode | POM |
| Source | AUSTRIA |
| Agent | IBN KHALDOON DRUG STORE |
| Retail Price | 680.50 AED |
Indications
Fludarabin Infusion is used for:
For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Fludarabine phosphate :
Mechanism of Action
Fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite appears to act by inhibiting DNA polymerase alpha, ribonucleotide reductase and DNA primase, thus inhibiting DNA synthesis. The mechanism of action of this antimetabolite is not completely characterized and may be multi-faceted.
Note
Fludarabin 25mg/ml Infusion manufactured by Ebewe Pharma Ges. m.b.H Mfg. KG. Its generic name is Fludarabine phosphate. Fludarabin is availble in United Arab Emirates.
Farmaco UAE drug index information on Fludarabin Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.